Skip to main content
. 2022 Jun 6;24(6):872–884. doi: 10.1038/s41556-022-00925-9

Fig. 3. HK2 localizes to the nuclei of haematopoietic stem and progenitor cells.

Fig. 3

a, Fluorescence intensity of nuclear HK2 in haematopoietic cell populations from cord blood. A.u., arbitrary units; n = 183 cells examined from three biological samples. b, CD34+-enriched normal haematopoietic cells were transduced with NLS1–HK2 or control vector and injected into the right femur of NOD/SCID-GF mice (n = 4 (EV) and 5 (NLS1–HK2) mice). Engraftment of transduced cord blood cells in the left femur of mice was measured using flow cytometry 8 weeks after the injection. c, Cells from b were injected into secondary mice and the engraftment efficiency was measured 8 weeks later using flow cytometry (n = 5 mice per group). d, Confocal microscopy images of HK2 and Tom20 staining in bone marrow cells from Vav-NLS–HK2 mice and control littermate wild-type mice. Scale bar, 10 µm. Images are representative of n = 20 biologically independent samples. e, Percentage of linckit+Sca+CD48CD150+ cells in the bone marrow of the Vav-NLS–HK2 mice and their littermate controls (n = 12 (wild-type control) and 10 (Vav-NLS–HK2) mice). f, Percentage of granulocyte-monocyte and common myeloid progenitor (left), and megakaryocyte–erythroid progenitor (right) cells in the bone marrow of the Vav-NLS–HK2 mice and their littermate controls (n = 9 (wild-type control) and 6 (Vav-NLS–HK2) mice). g, Bone marrow cells from Vav-NLS–HK2 mice or their littermates (CD45.2+; donor) were co-transplanted with CD45.1+ bone marrow cells as competitors (1:1 ratio) into B6.SJL recipient mice (CD45.1+). Reconstitution units (CD45.2/CD45.1) were analysed in the peripheral blood of the chimaera mice over the specified period using flow cytometry (n = 10 mice per group). h, Reconstitution efficacy in the bone marrow from g was analysed at week 12 (n = 10 mice per group). b,c,eh, Statistical analyses were performed using a two-tailed unpaired Student’s t-test. Data represent the mean ± s.e.m. MPP, multipotent progenitors; MLP, multilymphoid progenitors; CMP, common myeloid progenitors; GMP, granulocyte-monocyte progenitors; and MEP, megakaryocyte–erythroid progenitors.

Source data